MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

    O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

    Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…
  • 2017 International Congress

    Study Design of an Efficacy and Safety Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of APL-130277 in the Treatment of OFF Episodes (CTH-300)

    C.W. Olanow, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro (New York, NY, USA)

    Objective: To review the unique features of the ongoing Phase 3 trial for APL-130277.  Background: Patients with Parkinson’s disease (PD) frequently develop problematic OFF episodes…
  • 2017 International Congress

    Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, A. Kühn, L. Timmermann, M. Pötter-Nerger, P. Eldridge, J. Volkmann, J. Fitzgerald, A. Schnitzler, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To investigate the effectiveness and safety-related real-world outcomes of a multiple-source, constant current Deep Brain Stimulation (DBS) System in the treatment of levodopa-responsive Parkinson’s…
  • 2017 International Congress

    Improvement on gait in Parkinson’s disease patients using Honda stride management assist device

    N. Kawashima, M. Matsuhashi, T. Hamano, K. Nagami, T. Furukado, M. Iijima, M. Isogai, M. Komachi, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the effect of a wearable exoskeleton stride management assist device (SMAD: Honda R and D Corporation, Japan) on gait in Parkinson's disease…
  • 2017 International Congress

    A prospective randomized cross-over study of telemedicine system in Parkinson’s disease

    S. Sekimoto, G. Oyama, T. Hatano, F. Sasaki, R. Nakamura, T. Jo, Y. Shimo, N. Hattori (Tokyo, Japan)

    Objective: To investigate the validity of telemedicine system in Parkinson’s disease(PD). Background: PD patients may be difficult to visit the hospitals because of decline of…
  • 2017 International Congress

    Spinal cord stimulation as therapeutic option in gait disorder in Parkinson disease.

    H. Cécile, D'H. Vincent, B.M. MALEK, p.-k. nathalie, t. Jean-Batiste, Z. MARC, B. Jean-Philippe (PARIS, France)

    Objective: We aim to study the effect of spinal cord stimulation over gait in parkinson disease without pain nor neuropathy. Background: Axial symptoms in the course…
  • 2017 International Congress

    Safety of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients receiving ≥ 2000 mg daily dose of levodopa

    C. Zadikoff, J. Boyd, S. Dubow, L. Bergmann, W. Robieson, H. Ijacu, J. Benesh (Chicago, IL, USA)

    Objective: To examine the safety of levodopa-carbidopa intestinal gel treatment (LCIG, carbidopa-levodopa enteral suspension in the US) in advanced Parkinson’s disease (PD) patients that received…
  • 2017 International Congress

    A Preliminary Study: Validity and Reliability of Turkish Version of Fatigue Severity Scale (FSS) in Patients with Parkinson’s Disease (PD)

    E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)

    Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of FSS. Background: Fatigue is a frequent, non-motor…
  • 2017 International Congress

    Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor

    R. Bhidayasiri, J. Sringean, S. Chaiwong, C. Anan, K. Boonpang, K. Sakdisornchai, O. Jitkritsadakul, P. Jagota (Bangkok, Thailand)

    Objective: To evaluate the efficacy of rotigotine transdermal patch, using a wearable sensor, to treat PD patients with nocturnal immobility. Background: Nocturnal hypokinesia is a…
  • 2017 International Congress

    Resting state modulations of EEG low frequency bands in Parkinson’s disease.

    A. Pal, N. Mehta, R. Sharma (New Delhi, India)

    Objective: Dynamics in EEG activity such as slowing in low-frequency bands has been reported in Parkinson’s disease (PD). The objective of the present study was…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley